BioSpace News Archive

Immodulon, a late-stage clinical biotechnology company focused on developing a broad spectrum immunomodulator to improve the lives of patients suffering from difficult-to-treat cancers, today announced that Gertjan Bartlema, Chief Executive Officer, and Peter Greaney, PhD, Chief Business Officer, will participate in meetings with investors at the Wells Fargo Virtual Private Biotech Symposium on Monday, May 6, 2024.

Corcept Therapeutics Incorporated today announced completion of enrollment in CATALYST, a Phase 4 trial examining the prevalence of hypercortisolism.

Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.

Technoderma Medicines, Inc. (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing patients in its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ointment.

Octapharma USA , Inc. announced the U.S. Food and Drug Administration (FDA) has granted orphan drug exclusivity for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease (VWD).

INOVIO today announced that management will participate in the following investor conferences during the month of May.

Artivion, Inc. today announced the presentation of new clinical data from the On-X Low INR post-market study and AMDS PERSEVERE Trial at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting in Toronto, Canada.

Bonum Therapeutics today announced that it will present data on a new class of protein therapeutics with the potential for increased safety and efficacy in a wide range of biologic targets and disease areas.

Cognito Therapeutics announced today a poster presentation at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2024 Meeting, held May 5-8 in Atlanta, GA.

Spectrum Dynamic’s customers will benefit from Hermia’s best-in-class nuclear medicine and dosimetry software applications to fully leverage the unique technology and image quality of VERITON-CT scans.